Invuity is part of the medical instruments and equipment industry and is in the healthcare sector. The company CEO is Scott D. Flora. Invuity Inc develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities during open minimally invasive and minimal access procedures.



Previous Intraday Performance:

The IVTY shares had a previous change of -0.14% which opened at 7.40 and closed at 7.39. It moved to an intraday high of 7.40 and a low of 7.39.

PR Newswire:  WeissLaw LLP Investigates Invuity, Inc. Acquisition

Historical Performance:

Over the last five trading days, IVTY shares returned 0.00% and in the past 30 trading days it returned 0.54%. Over three months, it changed 71.86%. In one year it has changed -20.11% and within that year its

52 week high was 9.55 and its 52 week low was 2.35. IVTY stock is 214.47% above its 52 week low.

Our calculations result in a 200 day moving average of 4.50 and a 50 day moving average of 6.21. Right now, IVTY stock is trading 64.12% above its 200 day moving average.

PR Newswire:  WeissLaw LLP Investigates Invuity, Inc. Acquisition

Liquidity:

The company has a market cap of $177.9m with 24.1m shares outstanding and a float of 23.0m shares. Trading volume was 102,783 shares and has experienced an average volume of 535,216 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.

Earnings:

The last annual reported EPS for Invuity was -2.34 which ended on 31st of December 2017. Based on 5 analyst estimates, the consensus EPS for the next quarter is -0.26.

Below was the last reported quarterly diluted earnings per share:

2ndQtr 2018Reported 08-02-2018: -0.37
1stQtr 2018Reported 05-03-2018: -0.62
4thQtr 2017Reported 02-13-2018: -0.43
3rdQtr 2017Reported 11-07-2017: -0.52
2ndQtr 2017Reported 07-25-2017: -0.61

The long-term trend of the EPS is a vital number as it helps understand the future potential of Invuity; the EPS growth rate, as it is typically called, is usually expressed as a percentage, which at this time is hard to estimate, but revenue growth has been -1.00% over the last twelve months.



Indicators Also to Watch:

Based on the latest filings, there is 4.60% of insider ownership and 88.60% of institutional ownership. Short-interest was 157,848, which was 0.66% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.13. This stock has some short interest, but it might be normal and no need to worry if long the position.

The beta was calculated to be -0.01.

Fundamental Numbers:

Based on last reported financials, the company’s return on assets is -75.94%, profit margin is -88.22%, price-to-sales is 5.70 and price-to-book is 76.29.

Company Score Card:

Results are out of six:
 2  : Growth Expectations Result
 4  : Financial Safety Result
 0  : Past Performance Result
 0  : Valuation Result
 0  : Dividend Safety Result
 1  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).

LEAVE A REPLY

Please enter your comment!
Please enter your name here